These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14520724)

  • 1. Effect of montelukast on time-course of exhaled nitric oxide in asthma: influence of LTC4 synthase A(-444)C polymorphism.
    Whelan GJ; Blake K; Kissoon N; Duckworth LJ; Wang J; Sylvester JE; Lima JJ
    Pediatr Pulmonol; 2003 Nov; 36(5):413-20. PubMed ID: 14520724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma.
    Sandrini A; Ferreira IM; Gutierrez C; Jardim JR; Zamel N; Chapman KR
    Chest; 2003 Oct; 124(4):1334-40. PubMed ID: 14555563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of montelukast on bronchial provocation tests and exhaled nitric oxide levels in asthmatic patients.
    Berkman N; Avital A; Bardach E; Springer C; Breuer R; Godfrey S
    Isr Med Assoc J; 2003 Nov; 5(11):778-81. PubMed ID: 14650101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of exercise training and montelukast in children with mild asthma.
    Bonsignore MR; La Grutta S; Cibella F; Scichilone N; Cuttitta G; Interrante A; Marchese M; Veca M; Virzi' M; Bonanno A; Profita M; Morici G
    Med Sci Sports Exerc; 2008 Mar; 40(3):405-12. PubMed ID: 18379200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of beta2-agonist treatment and spirometry on exhaled nitric oxide in healthy children and children with asthma.
    Kissoon N; Duckworth LJ; Blake KV; Murphy SP; Lima JJ
    Pediatr Pulmonol; 2002 Sep; 34(3):203-8. PubMed ID: 12203849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Montelukast 10 mg improves nasal function and nasal response to aspirin in ASA-sensitive asthmatics: a controlled study vs placebo.
    Micheletto C; Tognella S; Visconti M; Pomari C; Trevisan F; Dal Negro RW
    Allergy; 2004 Mar; 59(3):289-94. PubMed ID: 14982510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
    Szefler SJ; Phillips BR; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Zeiger RS; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM
    J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma.
    Montuschi P; Mondino C; Koch P; Barnes PJ; Ciabattoni G
    J Allergy Clin Immunol; 2006 Aug; 118(2):347-53. PubMed ID: 16890757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged effect of montelukast in asthmatic children with exercise-induced bronchoconstriction.
    Kim JH; Lee SY; Kim HB; Kim BS; Shim JY; Hong TJ; Hong SJ
    Pediatr Pulmonol; 2005 Feb; 39(2):162-6. PubMed ID: 15633203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placebo-controlled study of montelukast and budesonide on short-term growth in prepubertal asthmatic children.
    Pedersen S; Agertoft L; Williams-Herman D; Kuznetsova O; Reiss TF; Knorr B; Dass SB; Wolthers OD
    Pediatr Pulmonol; 2007 Sep; 42(9):838-43. PubMed ID: 17659605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment with albuterol versus montelukast for exercise-induced bronchospasm in children.
    Raissy HH; Harkins M; Kelly F; Kelly HW
    Pharmacotherapy; 2008 Mar; 28(3):287-94. PubMed ID: 18294107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Montelukast in asthmatic patients 6 years-14 years old with an FEV1 > 75%.
    Becker A; Swern A; Tozzi CA; Yu Q; Reiss T; Knorr B
    Curr Med Res Opin; 2004 Oct; 20(10):1651-9. PubMed ID: 15462699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast.
    Bisgaard H; Loland L; Oj JA
    Am J Respir Crit Care Med; 1999 Oct; 160(4):1227-31. PubMed ID: 10508811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma.
    Fritscher LG; Rodrigues MT; Zamel N; Chapman KR
    Respir Med; 2009 Feb; 103(2):296-300. PubMed ID: 18805684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of montelukast during the allergy season in pediatric patients with persistent asthma and seasonal aeroallergen sensitivity.
    Papadopoulos NG; Philip G; Giezek H; Watkins M; Smugar SS; Polos PG
    J Asthma; 2009 May; 46(4):413-20. PubMed ID: 19484680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure to tobacco smoke increases leukotriene E4-related albuterol usage and response to montelukast.
    Rabinovitch N; Strand M; Stuhlman K; Gelfand EW
    J Allergy Clin Immunol; 2008 Jun; 121(6):1365-71. PubMed ID: 18439662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variations in exhaled nitric oxide in children with asthma during a 1-week stay in a mountain village sanatorium.
    Barreto M; Rennerova Z; Montesano M; Alterio A; Trubacova D; Ronchetti R; Villa MP
    J Asthma; 2008 Aug; 45(6):453-8. PubMed ID: 18612896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Montelukast does not affect exercise performance at subfreezing temperature in highly trained non-asthmatic endurance athletes.
    Sue-Chu M; Sandsund M; Holand B; Bjermer L
    Int J Sports Med; 2000 Aug; 21(6):424-8. PubMed ID: 10961518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined mediator blockade or topical steroid for treating the unified allergic airway.
    Barnes ML; Menzies D; Fardon TC; Burns P; Wilson AM; Lipworth BJ
    Allergy; 2007 Jan; 62(1):73-80. PubMed ID: 17156345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of montelukast on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.
    Van Hecken A; Depré M; Verbesselt R; Wynants K; De Lepeleire I; Arnout J; Wong PH; Freeman A; Holland S; Gertz B; De Schepper PJ
    J Clin Pharmacol; 1999 May; 39(5):495-500. PubMed ID: 10234597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.